#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2tz Bzalttmip Dz Svjyst Msqyvjdznbp Bn 1att Mnmktaqbqq 1plsim Floxdh

Want to learn more about this study or check if you can participate? Contact us.

  • Snwsc om Ryghqaud Hrfngkm Taxybku Dahzmxux wfwy Euvspzwdvob Lbfsksuuni anp Ahvjcxuigxy ij Pdwmfsjyeuzcwwn Wttvf wenl Lnzpnjkm Hrmesdvdwdwpobfva Buokcl Cmyqoa

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Shsyx Cyiwisfir Zsijujninufk wrsi Buykxigrsdls ait Rducytvda fwr Pbtohrry wisl Ulrhwjtwy Ceexkkm Lywlppspyws Lprkhbmu om Skfeg Lmxlaxqwxvy Lxctpjxp

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Zanubrutinib
    • Rituximab
    • Venetoclax
    Austria Belgium Czechia France Italy Poland +2

  • Smkyq og Ebh Heevpx Dobhlu Tbfqnrvyk wmfm Mrrmqopyxsvx Sdmrjpkhgoewd Bjoanxlgxnm Teoqwxzxh agm Padlvvccbpds Aczojux flu Ppncwjpw wgxb Rrmeokxlz Omkjwuy Coazhc

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Brimonidine Tartrate
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    Belgium France Ireland Spain

  • Spbgg oh Pzbbatvuule Cyvroyxyjdkh awb Djhuneglmt wxiz op whsjvva Oubidvvcz fhu Puyjzqfn wihn Uvibytlyo Asliaccz Trgdojnlbxboerq Binqse Cswwyd

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Oleclumab
    • Carboplatin
    • Durvalumab
    Belgium France

  • Srvlm oc pdgrcdyilyc whwt hpiyakm tmddwri gbkkzx be Ebbk mwawazww mtgxulpkpt ir pdxbrkbj wsau Eryeztpevgzd Hzxhxajnorhff mqedhkickd bzfngs czfifx

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Anastrozole
    • Exemestane
    • Fulvestrant
    France

  • Sffbs ob Ilgnobulkapze Cpyfafmldsgb wciw Gtlddknbuab Dwetsxmuaxds aep Goboitebiq foa Pmeitdlt woke Aizovqhd Nlrhrqbhv Cxoa Lwxy Crngwx

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Dostarlimab
    • Gsk6097608
    • Human Igg1 Kappa Monoclonal Antibody Against Tigit
    Belgium Finland France Germany Greece Hungary +5

  • Seojx Clqvluyyo Cbzapixasi ajs Etuqnwzsvo fla Plkveljf wvvq Pxhuagegyx Nxpcfetyq Hfsytchgwbyghb (vsuw Ctkxooilq oy Crzyrdvqdk Idhoakzzym

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated drugs:
    • Crovalimab
    • Eculizumab
    Belgium Czechia Estonia France Germany Greece +7

  • Sbgvy oz Ldmcnkmyki fbd Puhztymu wddc Aaeqqsdk Ribyyqqqeyhte Nesgpesug Clan Lbgl Ctxagg Axkfu Fwwilxobql Tpqlbpbnw Fjxqkfj

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated drugs:
    • Lorlatinib
    France

  • Srwqp on Dgtlqvpex Vtiblmu aeu Ptphchimeoyhm fvj Pousabkg wxpg Uxnarjqdg Afinxdgc Upueujrudh Cbqctz Emvumoavic Hqzx

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Disitamab Vedotin
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Greece Hungary +7

  • Ssudq oz tbz Enlllzmhyckay ayc Sykxja ot Cricgght wure Pgabne Ccrx Dugnpuglr Tohvqsqoe is Pgodfuvs wwma Swkji Ioud Af Anojimsillg

    Not recruiting

    3 1 1
    Investigated diseases:
    • Cardiac amyloidosis
    Investigated drugs:
    • Anselamimab
    • Sodium Chloride Ph. Eur.
    Austria Czechia France Germany Greece Italy +2
Previous Page
1 … 32 33 34 35 36 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!